Table 3.
Comparison of WWP2 expression among varied groups
| Items | RFH | FL | GCB DLBCL | non-GCB DLBCL | BL |
|---|---|---|---|---|---|
| RFH | - | 0.007 | < 0.001 | < 0.001 | 0.050 |
| FL | - | - | 0.055 | 0.066 | 0.785 |
| GCB DLBCL | - | - | - | 0.815 | 0.067 |
| non-GCB DLBCL | - | - | - | - | 0.073 |
| BL | - | - | - | - | - |
Data was presented as P value. WWP2 expression was scored as 0-Negative (-), 1-Positive (+), 2-Positive (++), 3-Positive (+++). Comparison was determined by Wilcoxon rank sum test. P < 0.05 was considered as significant and presented as bold font. WWP2, WW Domain Containing E3 Ubiquitin Protein Ligase 2; RFH, reactive follicular hyperplasia; FL, follicular lymphoma; GCB DLBCL, germinal center B-cell-like diffuse large B-cell lymphoma; non-GCB DLBCL, non-germinal center B-cell-like diffuse large B-cell lymphoma; BL, Burkitt’s lymphoma.